Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

12/11/2021 06:01

Nov 12 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2021        Sep 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               1 mln             2 mln     
                 (-81.5 pct)         (-27.5 pct)       (-20.1 pct)  
  Operating     loss 721 mln        loss 772 mln        loss 1.85   
  Recurring     loss 723 mln        loss 777 mln        loss 1.85   
  Net           loss 723 mln        loss 774 mln        loss 1.85   
  EPS          loss 14.20 yen      loss 17.05 yen    loss 36.49 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T